Navigation Links
AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell
Date:12/4/2009

HOUSTON, Dec. 4 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education course published by PennWell Corporation, a leader in professional education for many industries, including medicine and dentistry. The course focuses on patient views about orthodontic treatment, a summary of treatment biomechanics, factors that increase treatment duration, and the role that pulsatile forces can play in modulating periodontal biology and accelerating orthodontic treatment. The technology supporting the AcceleDent System involves the application of pulsatile forces. The course can be accessed directly through PennWell's dental education website http://www.ineedce.com/

(Photo: http://www.newscom.com/cgi-bin/prnh/20091204/DA21078)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that an orthodontic patient wears in the mouth for 20 minutes daily to accelerate orthodontic tooth movement. A Phase I clinical trial in 2008 in Houston, Texas demonstrated the safety of the device. The first case in private practice was initiated in October 2009 in the UK, following EU approval.

The course is a peer-reviewed publication titled "Advances in Orthodontic Treatment," and was authored by Jeremy J. Mao, DDS, PhD, who recently lectured internationally on the biological action of pulsatile force, and Chung H. Kau, DDS, MScD, MBA, PhD, MOrth, FDS, FFD (Ortho), FAMS (Ortho), who oversaw the Phase I clinical trial that featured the first use of the AcceleDent technology in patients at the University of Texas Dental Branch. The course is intended for orthodontists and dental professionals and awards 4 CE credits. PennWell is an ADA CERP (Continuing Education Recognition Program) provider.

Dr. Jeremy Mao observed, "We believe that a great deal of knowledge has been unveiled in recent years as it relates to pulsatile forces and biological response of alveolar bone. The scientific data have important implications in the rate of orthodontic treatment. This course is a timely opportunity to create awareness around these concepts." He continued, "The Phase I clinical trial conducted at the University of Texas Dental Branch represents scientific validation of years of animal data on the effectiveness of pulsatile forces." Brent Tarver, VP Clinical Affairs for the Company added, "OrthoAccel is committed to its investment in a clinical strategy that is ultimately intended to not only elaborate the scientific basis for AcceleDent, but also discover new ways to improve orthodontic care."

OrthoAccel is presently controlling availability of AcceleDent in the UK to a select group of orthodontic specialists before a broader release there in October 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com or requested via info@orthoaccel.com

Media Contact Michael K. Lowe, CEO +1 (832) 631-1659

About PennWell Corporation

PennWell Corporation is a diversified business-to-business media and information company that provides quality content and integrated marketing solutions for the following industries: Oil and gas, electric power, renewable energy, water, electronics, semiconductor, contamination control, optoelectronics, fiberoptics, enterprise storage, fire, emergency services and dental. Founded in 1910, PennWell publishes 75 print and online magazines and newsletters, conducts 60 conferences and exhibitions on six continents, and has an extensive offering of books, maps, web sites, research and database services. In addition to PennWell's headquarters in Tulsa, Oklahoma, the company has major offices in Nashua, New Hampshire; Houston, Texas; London, England; Fairlawn, New Jersey; Moscow, Russia; and Hong Kong, China. For additional information about PennWell, visit www.pennwell.com.

SOURCE OrthoAccel Technologies, Inc.


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices
2. Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers
3. Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
4. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
5. Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
6. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
7. Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors
8. Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research
9. Derma Sciences Files S-1 Registration Statement
10. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
11. Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):